Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An o...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador-Martín, Sara, Kaczmarczyk, Bartosz, Álvarez, Rebeca, Navas-López, Víctor Manuel, Gallego-Fernández, Carmen, Moreno-Álvarez, Ana, Solar-Boga, Alfonso, Sánchez, Cesar, Tolin, Mar, Velasco, Marta, Muñoz-Codoceo, Rosana, Rodriguez-Martinez, Alejandro, Vayo, Concepción A., Bossacoma, Ferrán, Pujol-Muncunill, Gemma, Fobelo, María J., Millán-Jiménez, Antonio, Magallares, Lorena, Martínez-Ojinaga, Eva, Loverdos, Inés, Eizaguirre, Francisco J., Blanca-García, José A., Clemente, Susana, García-Romero, Ruth, Merino-Bohórquez, Vicente, González de Caldas, Rafael, Vázquez, Enrique, Dopazo, Ana, Sanjurjo-Sáez, María, López-Fernández, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830359/
https://www.ncbi.nlm.nih.gov/pubmed/33429950
http://dx.doi.org/10.3390/pharmaceutics13010077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830359/
https://www.ncbi.nlm.nih.gov/pubmed/33429950
http://dx.doi.org/10.3390/pharmaceutics13010077

Ejemplares similares